MENU
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

A.I. Advisor
published Earnings

OVID is expected to report earnings to rise 11.93% to -15 cents per share on August 18

Ovid Therapeutics OVID Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Est.
$-0.14
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.34
The last earnings report on May 13 showed earnings per share of -14 cents, meeting the estimate of -14 cents. With 412.13K shares outstanding, the current market capitalization sits at 22.12M.
View a ticker or compare two or three
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com